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Abstract: The study objective was to assess the role of the JAK/STAT pathway in the induction of nitric oxide (NO) synthesis with
the involvement of inducible nitric oxide synthase (iNOS) and in the generation of superoxide anion radical by human neutrophils
(PMNs) exposed to N-nitrosodimethylamine (NDMA). Isolated PMNs were incubated in the presence of NDMA. The expression of
the study proteins in the cytoplasmic and nuclear fraction was determined by western blotting. Total NO was assayed in cell cultures
by Griess reaction. The ability of PMNs to generate superoxide anion radical was assessed using the cytochrome-c reduction test. The
current results indicate that NDMA potentiates the expression of iNOS and phospho-JAK2 in the cytoplasmic fraction of human PMNs.
Moreover, it increases the expression of phospho-STAT1 and phospho-STAT3 in both fractions of the cells studied. PMNs treated with
NDMA showed greater capability to release NO and superoxide anion radical, which was reduced after administration of the JAK/
STAT pathway inhibitor. The current findings indicate that NDMA in PMNs activates the JAK/STAT pathway, which plays a role in the
production of NO with the involvement of iNOS and in the generation of superoxide anion radical by these cells.
Key words: Neutrophils, N-nitrosodimethylamine, inducible nitric oxide synthase, nitric oxide, superoxide anion radical, JAK/STAT

1. Introduction
Nitrosamines are compounds of very high biological
activity. Among them is N-nitrosodimethylamine
(NDMA), a xenobiotic with widespread occurrence
in the human environment. NDMA is used in certain
technological processes in the plastic, metallurgical, and
rubber industries. It is present in cigarettes and tobacco
smoke, processed food, heat-treated food, and pickled
products. The levels of NDMA noted in food samples
range from tiny fractions to several micrograms per
kilogram, which, according to some authors, poses a real
risk to health (Tricker and Preussmann, 1991; Dobo et al.,
1997; Zeilmaker et al., 2010).
High consumption of the precursors, amines and
nitrosating agents, leads to endogenous production of
N-nitrosamines. The intraorganic biosynthesis of NDMA
involves secondary amines (e.g., dimethylamine) and
tertiary amines (e.g., N,N-dimethyl-p-hydroxyphenylethylamine) (Waller and Goscinski, 1999). Reaction
kinetics for nitrosation are affected by pH, amine alkalinity,
and temperature. A study conducted by Jablonski et al.
(2006) showed maximum nitrosylation velocity at a pH
of 3–4.5. The level of hydrogen ions in this range is most
* Correspondence: rwioletta@umb.edu.pl

common in the acidic environment of the stomach or in an
inflammatory focus.
Up to now, observations have shown that NDMA
exerts a toxic action, inducing morphological and
functional disorders in many tissues and organs (Aiub et
al., 2011). Its mutagenic and cancerogenic effects have also
been proven (Glavin et al., 2008). This xenobiotic has been
found to influence the activity of the immune cells, such
as neutrophils (PMNs), which are a key source of reactive
oxygen and nitrogen species, including superoxide anion
radical and nitric oxide (NO) (Ratajczak-Wrona et al.,
2011).
NO produced in PMNs can interact with superoxide
anion radical released by these cells during phagocytosis to
form toxic peroxynitrite (V) (Sohn et al., 2003; Chanda et
al., 2013; Demir et al., 2013). This compound is converted
to nitrate ion (III) and shows potential to nitrosate systemic
amines, which in consequence leads to the synthesis of
nitrosoamines in the body (Vermeer et al., 2001).
Inducible nitric oxide synthase (iNOS) is one of the
enzymes responsible for the synthesis of NO (Demirci et al.,
2001; Konuk et al., 2012). Its activity is regulated by various
signaling pathways, e.g., mitogen-activated protein kinases
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(MAP kinases), which affect the expression of numerous
transcription factors (Bek et al., 1999; Lirk et al., 2002).
Our previous study revealed the role of MAP kinases p38
and JNK in the activation of transcription factors, such as
c-Jun and NF-kB p65, engaged in the regulation of iNOS
expression in human PMNs exposed to NDMA in healthy
subjects (Ratajczak-Wrona et al., 2013a).
There have been some reports that NO synthesis with
the involvement of iNOS is also controlled by signaling
pathways other than MAP kinases. Sareila et al. (2006)
demonstrated that the blockade of the Janus kinase/
signal transducers and activators of transcription (JAK/
STAT) signaling pathway inhibits iNOS expression in
the IFN-g stimulated macrophages. Similar observations
were reported by Kleinert et al. (1998) in epithelial cells
stimulated with a cytokine mixture (IFN-g, TNF-a, and
IL-1b).
The JAK/STAT pathway has been shown to also be
activated as a result of cell stress triggered by reactive
oxygen species, apart from cytokines and growth factors
(Freitas et al., 2010). The JAK kinases include JAK1, JAK2,
JAK3, and Tyk2; JAK2 kinase is considered to be the most
conservative isoform of this family (Yamaoka et al., 2004).
The activation of JAK kinases causes phosphorylation of
tyrosine or serine residues in the C-terminal domain of
STAT proteins. This enables homo- and heterodimerization
of STAT proteins, with the involvement of SH2 domains
and their active transport to the cell nucleus, where STAT
dimers bind to interferon activated site (GAS) or interferon
stimulated gene (ISG) sequences in the promoter regions
of genes and activate their transcription (ChatterjeeKishore et al., 2000; Murray, 2007). Signaling processes
of the JAK/STAT pathway may also undergo negative
regulation, mainly via dephosphorylation of STAT factors
and synthesis of specific inhibitors of the protein inhibitors
of activated STAT (PIAS) or suppressors of the cytokine
signaling (SOCS/SSI/JAB) family. The ultimate action
of the stimulator seems to be the result of opposing and
at the same time activated signal transmission pathways
(Greenhalgh and Hilton, 2001; Levy and Darnell, 2002).
The STAT type proteins include STAT1, STAT2,
STAT3, STAT4, STAT5a, STAT5b, and STAT6. It is thought
that the transcription factors STAT1 and STAT3 have
opposite functions in the regulation of cell proliferation,
differentiation, and apoptosis and in the induction of the
immune response to tumor antigens (Ihle, 2001; Levy and
Darnell, 2002).
The present study objective was to assess the role of
the JAK/STAT pathway in the induction of NO synthesis
with the involvement of iNOS and in the generation of
superoxide anion radical by PMNs exposed to NDMA.
Since the activation of the JAK/STAT pathway is
manifested by the presence of phospho-JAK2 kinase,
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phospho-STAT1, and phospho-STAT3 proteins, their
expression may either confirm or exclude the involvement
of this signaling pathway in iNOS activation.
The knowledge of the expression of the STAT
transcription factors, e.g., STAT1 and STAT3 induced by
JAK2 kinase, in both the cytoplasmic and nuclear fraction
of PMNs exposed to NDMA will help fully elucidate the
basic molecular mechanism of action of this xenobiotic on
the leukocyte population.
2. Materials and methods
2.1. Reagents
NDMA, 3-(4,5-dimethylthazol-2-yl)-2,5-diphenyl-2Htetrazolium bromide (MTT), dimethyl sulfoxide (DMSO),
cadmium, Griess reagent, cytochrome-c, superoxide
dismutase (SOD), and BCIP/NBT Liquid Substrate System
were purchased from Sigma (Steinheim, Germany). (E)N-Benzyl-2-cyano-3-(3,4-dihydroxyphenyl)acrylamide
(AG490) was obtained from Calbiochem (San Diego, CA,
USA). Laemmli buffer, Tris-buffered saline (TBS)/casein
buffer, and TBS-T (containing Tris-buffered saline and
Tween 20) were purchased from Bio-Rad Laboratories
(Hercules, CA, USA).
2.2. Antibodies
Monoclonal mouse antibody against the iNOS and betaactin, and polyclonal goat antibodies against phosphoJAK2, phospho-STAT1, and phospho-STAT3 protein were
purchased from Santa Cruz Biotechnology (Heidelberg,
Germany). Goat antimouse IgG antibody conjugated
with alkaline phosphatase (AP) and donkey antigoat
IgG antibody conjugated with alkaline phosphatase
were obtained from Vector Laboratories (Burlingame,
CA, USA). Monoclonal mouse antibody against the
poly(ADP-ribose)polymerase (PARP-1) was purchased
from Calbiochem.
2.3. Isolation and incubation of PMNs
The study involved a group of 20 healthy people, aged from
25 to 40 years old, who were volunteer blood donors from
the Regional Centre for Transfusion Medicine in Bialystok,
Poland. Males were chosen to avoid possible influences due
to endogenous hormones on the experimental findings.
The study was approved by the Ethics Committee of the
Medical University of Bialystok (R-I-002/11/2010) and all
persons gave written informed consent.
PMNs were isolated from heparinized (10 U/mL;
Heparin, Polfa, Lodz, Poland) whole blood by density
centrifugation using Gradisol G gradient, 1.115 g/mL
(Polfa) (Zeman et al., 1988). Sera were obtained from
blood samples collected without anticoagulant agents. The
PMNs were further purified by positive selection using the
MidiMACS Separation System (Miltenyi Biotec, Bergisch
Gladbach, Germany) that employs MicroBeads conjugated
to monoclonal antihuman CD16 antibodies.
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PMNs were suspended at a concentration of 5 × 106
cells/mL in Hanks’ Balanced Salt Solution 1X (Invitrogen,
Carlsbad, CA, USA) containing the subject’s own serum
(7.4%, 20/270 µL), 100 U penicillin/mL, and 50 ng
streptomycin (Polfa Trachomin SA, Warsaw, Poland).
The cells (200 µL aliquots) were then placed into wells
of microplates (Microtest III-Falcon, BD Biosciences,
Bedford, MA, USA) and incubated for 2 h at 37 °C in a
5% CO2 incubator (NuAire, US AutoFlow, Plymouth,
MN, USA). PMNs in the wells were then treated with 20
µL NDMA to attain a final concentration of 0.74 µg/µL
in the well; control wells received vehicle only. The PMNs
were then cultured a further 2 h before supernatants
were collected. Assessments of viability (via trypan blue
exclusion) showed that PMNs were >93% viable after the
treatment.
In order to determine the role of JAK/STAT pathway
in the regulation of iNOS expression in PMNs exposed to
NDMA, selective inhibitors of this pathway were used. In
these studies, cells were preincubated with 30 µM, 50 µM,
or 100 µM AG490, a selective JAK/STAT pathway inhibitor,
for 1 h before the addition of NDMA. Preliminary studies
showed that the presence of the inhibitor did not affect cell
viability.
2.4. Cellular toxicity assay
Cytotoxic effect of NDMA on neutrophils was analyzed
by using the tetrazolium-based colorimetric assay (MTT
reduction assay). The MTT assay is dependent upon the
ability of mitochondrial dehydrogenase in living cells to
reduce the yellow MTT to a blue formazan product. It
has been shown that an increase in absorbance values
correlates to an increase in cellular enzymatic activity and
cell number. PMNs were plated in 96-well microplates at
1 × 106 cells/well in 0.2 mL of medium without NDMA
or at increasing doses of the xenobiotic: 1 µg/µL, 2 µg/µL,
3 µg/µL, and 4 µg/µL. After 2 h of incubation, 20 µL of
stock MTT solution (5 mg/mL) was added to each culture
well and plates were incubated for 1 h at 37 °C in a 5%
CO2 incubator. Plates were then centrifuged, the medium
was aspirated, and 200 µL of DMSO was added to lyse the
cells and dissolve the MTT formazan crystals. Plates were
mechanically agitated, and absorbance was measured at 570
nm by using a UVN-340 ASYS Hitech GmbH microplate
reader (Biogenet, Eugendorf, Austria). Experiments were
performed in triplicate, and data are expressed as the
percentage of MTT reduction compared to control cells
(unexposed PMNs). Metabolic activity decrease of studied
leukocytes was observed in cells incubated with NDMA
at >0.74 µg/µL concentration (Figure 1). This proved the
cytotoxic effect of this compound.
2.5. Protein isolation and western blotting
Cytoplasmic and nuclear extracts from PMNs (3 × 106
cells total/sample) were prepared using the NucBuster
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Figure 1. Cytotoxic activity of NDMA, evaluated by the MTT
assay. Data shown are means of 5 independent experiments.

Protein Extraction Kit (Calbiochem). Stepwise extraction
delivered 2 distinct cellular protein fractions: cytoplasmic
and nuclear. The concentration of protein in each was
determined with a Qubit Protein Assay Kit (Invitrogen).
An antibody against PARP-1 (1:5000) and against betaactin (1:100) was used as an internal control within the
nuclear and cytoplasmic fractions, respectively.
The extracts were suspended in Laemmli buffer,
loaded at 20 µg/well, and then electrophoresed over a 4%
stacking and 10% separating SDS-PAGE gel. The resolved
proteins were electrotransferred onto 0.45-µm pore-size
nitrocellulose membranes (Bio-Rad). These were then
blocked with TBS/casein buffer, washed with TBS-T (TBS
containing 0.05% Tween-20), and incubated with Qentix
Western Blot Signal Enhancer (Thermo Fisher Scientific,
Rockford, IL, USA). The membranes were then incubated
for 10 min at room temperature in SNAP (Protein
Detection System; Millipore, Billerica, MA, USA) with
1:100 dilutions of primary monoclonal antibody against
iNOS and primary polyclonal antibodies against phosphoJAK2, phospho-STAT1, or phospho-STAT3. After washing
with 0.1% TBS-T, the membrane was incubated at room
temperature with alkaline phosphatase antimouse IgG Ab
or antigoat IgG Ab (1:200). Immunoreactive protein bands
were then visualized using the BCIP/NBT Liquid Substrate
System, and intensities were determined using ImageJ
software (NIMH, Bethesda, MD, USA) and reported as
Arbitrary Units (AU).
2.6. Assay for nitrite production
Synthesis of NO was determined by an assay of the
culture supernatant for nitrite, a stable reaction product
of NO with molecular oxygen. Total NO concentration
is commonly determined as a sum of nitrite and nitrate
concentrations. NO production by PMNs was determined
using an indirect method based on measurement of
nitrite concentration in culture supernatants according
to Griess’ reaction (Schulz et al., 1999). In the samples
analyzed, nitrate was reduced to nitrite in the presence of
cadmium and then converted to nitric acid that yielded a
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color reaction with Griess reagent. Nitrite concentrations
were determined by spectrophotometric analysis at 540
nm with extrapolation from a standard curve prepared in
parallel. Nitric oxide products were expressed as µM/106
cells in 270 µL of supernatant.
2.7. Measurement of superoxide anion radical
generation
“Oxygen burst” in neutrophils was explored by detecting
the production of superoxide anion radical by these cells
according to McCord’s (1969) method with Bhuyan’s
modification, based on differences between light
absorbances of solutions containing nonreduced and
reduced cytochrome-c. Cytochrome-c does not permeate
through the plasma membrane, and thus its reduction by
superoxide anion radical in PMN supernatants indicates
superoxide anion radical release outside of the cell.
Cytochrome-c solution in phosphate buffer (KH2PO4/
K2HPO4), pH 7.8, containing 0.1 mM EDTA, was added to
2 parallel samples with isolated neutrophils. Cytochrome-c
concentration was 15 mg/mL. Superoxide dismutase, with
5000 U/mL activity, was added to the reference sample,
while buffer was added to the study sample. After addition
of NDMA to both test tubes, the samples were incubated
at 37 °C, and then absorbance was read at 550 nm in the
presence of deionized water. The generation of superoxide
anion radical, expressed as nmol of cytochrome-c reduced
per time, was calculated by using an absorbance coefficient
of 21.1 mmol/L–1 cm–1 at 550 nm.
2.8. Statistics
Results were analyzed using Statistica 9.1. (StatSoft,
Inc., Tulsa, OK, USA). Data distribution normality was
determined using a Kolmogorov–Smirnov test. Since
data were not normally distributed, for comparison of
variations between assayed groups, Mann–Whitney U
nonparametric tests were applied to unrelated results. P ≤
0.05 was accepted as statistically significant. All data are
presented as mean ± SE.
3. Results
3.1. Assessment of protein expression by western
blotting
Figure 2 presents the expressions of iNOS, phosphoJAK2, phospho-STAT1, and phospho-STAT3 in PMNs.
The exposure of PMNs to NDMA led to a simultaneous
increase in the expression of iNOS and phospho-JAK2
in the cytoplasmic fraction as compared to the cells
incubated without the xenobiotic. Higher expressions of
phospho-STAT1 and phospho-STAT3 were also observed,
both in the cytoplasmic and the nuclear fractions of these
cells. The expressions of phospho-STAT1 and phosphoSTAT3 in the cytoplasmic fraction of PMNs not exposed
and exposed to NDMA were higher than in the nuclear
fraction of the cells.
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In order to confirm the involvement of the JAK/STAT
pathway in the induction of iNOS expression in PMNs
treated with NDMA, a selective inhibitor of this pathway
was used in the experiment. In the presence of the JAK/
STAT pathway inhibitor, only at a concentration of 50 µM,
iNOS expression was lower in the cytoplasmic fraction of
PMNs exposed to NDMA as compared to the cells without
the inhibitor. When the inhibitor concentrations of 30 µM,
50 µM, and 100 µM were used, a reduction was noted in the
expression of phospho-JAK2 in the cytoplasmic fraction
of PMNs treated with NDMA as compared to the cells
without the inhibitor. Since AG490 reduced the expression
of both iNOS and phospho-JAK2 in PMNs exposed to
NDMA only at a concentration of 50 µM, the phosphoSTAT proteins were assessed in the 2 fractions using this
concentration. The expressions of phospho-STAT1 and
phospho-STAT3 were lower both in the cytoplasmic and
the nuclear fractions of the cells studied as compared to
the cells without the inhibitor.
3.2. Assessment of the level of total NO in PMNs
supernatants
Figure 3 shows the levels of total concentration of NO in
PMNs supernatants. The exposure of PMNs to NDMA
confirmed earlier observations and showed enhanced
release of nitric oxide as compared to the cells incubated
without the xenobiotic (Ratajczak-Wrona et al., 2013b).
In order to determine the role of the JAK/STAT
pathway in the production of nitric oxide with iNOS
by PMNs exposed to NDMA, its concentration was
assessed in the presence of the selective inhibitor. PMN
supernatants preincubated with the JAK/STAT pathway
inhibitor at a concentration of 50 µM and then incubated
in the presence of NDMA showed lower levels of total NO
than the supernatants without the inhibitor. However, as
in the case of iNOS, no changes were found in the levels of
total NO in the supernatants of PMNs preincubated with
the JAK/STAT pathway inhibitor at the concentrations of
30 µM and 100 µM.
3.3. Generation of superoxide anion radical by PMNs
Figure 4 presents the generation of superoxide anion
radical by PMNs. PMNs exposed to NDMA were found to
show higher potential to release superoxide anion radical
than the cells incubated without the xenobiotic, which is
consistent with previous findings (Ratajczak-Wrona et al.,
2013c).
In order to examine the involvement of the JAK/STAT
pathway in the production of superoxide anion radical by
PMNs exposed to NDMA, its generation was assessed in
the presence of the pathway inhibitor. Contrary to iNOS
expression and NO production, the presence of the AG490
inhibitor at concentrations of 50 µM and 100 µM resulted
in a decreased release of superoxide anion radical by
PMNs exposed to NDMA.
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Figure 2. Expressions of iNOS, phospho-JAK2, phospho-STAT1, and phospho-STAT3 in PMNs. (A) PMNs were treated with or
without AG490 (30 µM, 50 µM, or 100 µM) for 1 h before addition of NDMA (0.74 µg/µL). The cytoplasmic fractions obtained from
those cells were used to detect iNOS and phospho-JAK2 protein levels by western blotting. The results shown are representative of 5
independent experiments. Band intensity was quantified using ImageJ software and expressed in AU. Data shown are mean ± SE of
5 independent experiments. a - Value significantly different between cells without and with NDMA (P < 0.05); b - value significantly
different between cells treated with NDMA but preincubated without or with the inhibitor (P < 0.05). (B) PMNs were treated with or
without AG490 (50 µM) for 1 h before addition of NDMA (0.74 µg/µL). The cytoplasmic and nuclear fractions obtained from those
cells were used to detect phospho-STAT1 and phospho-STAT3 protein levels by western blotting. Band intensity was quantified using
ImageJ software and expressed in AU. Data shown are mean ± SE of 5 independent experiments. a - Value significantly different
between cells without and with NDMA (P < 0.05); b - value significantly different between cells treated with NDMA but preincubated
without or with the inhibitor (P < 0.05); c - value significantly different between cytoplasmic and nuclear fractions (P < 0.05).

4. Discussion
The current findings and previous observations confirm a
substantial effect of NDMA on iNOS expression and NO
production by human PMNs (Ratajczak-Wrona et al., 2013b).
The increase observed in the expression of phospho-JAK2 in
the cytoplasmic fraction and in the expression of phosphoSTAT1 and phospho-STAT3 in both the cytoplasmic and
nuclear fractions of PMNs treated with NDMA indicates that
the xenobiotic activates the JAK/STAT pathway in these cells.
The transport of STAT proteins to the nucleus from the
cytoplasm depends on the binding of specific importins on
their surface (STAT1 binds to α5 and β1, whereas STAT3
binds to α3, α6, and β1). As a result, STAT proteins are
transported to the cell nucleus by nuclear pores (Reich and
Liu, 2006).

Reports are available on the nuclear pool of STAT
proteins as phosphorylated proteins. According to Haspel
and Darnell (1999), STAT proteins are transported to
the cell nucleus from the cytoplasm only as a result of
their activation and eventual phosphorylation. Other
reports provide different data on localization of the STAT
protein. Sehgal et al. (2003) showed that the majority of
the phosphorylated STAT1 and STAT3 proteins remain in
the cytoplasm of human hepatoma Hep3B cells stimulated
with cytokines (IFN-g or IL-6) during both short- and
long-term incubation. The above data can explain the
higher expression of the phosphorylated STAT proteins in
the cytoplasmic fraction observed in the current study in
comparison with the nuclear fraction of PMNs exposed to
NDMA.
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Figure 3. Concentrations of total NO from PMNs. PMNs were treated with or without AG490 (30 µM, 50 µM, or 100 µM) for 1 h before
addition of NDMA (0.74 µg/µL). Two hours after addition of NDMA, the nitrite concentrations were measured as a marker of NO
production. a - Value significantly different between cells without and with NDMA (P < 0.05); b - value significantly different between
cells treated with NDMA but preincubated without or with the inhibitor (P < 0.05). Data are expressed as µM/106 cells (in 270 µL of
supernatant) and are shown as mean ± SE of 20 experiments.
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Figure 4. Superoxide anion radical generation (O2˙ˉ) for PMNs. PMNs were treated with or without AG490 (30 µM, 50 µM, or 100 µM)
for 1 h before addition of NDMA (0.74 µg/µL). Cells were incubated for 2 h and then analyzed for superoxide anion radical generation.
a - Value significantly different between cells without and with NDMA (P < 0.05); b - value significantly different between cells treated
with NDMA but preincubated without or with the inhibitor (P < 0.05). Data are expressed nmol O2˙ˉ/106 cells/time and are shown as
mean ± SE of 20 experiments.

The experiments conducted in our laboratory did not
show any differences in the expression between phosphoSTAT1 and phospho-STAT3 in any of the cell fractions
examined. However, the available data on the human
hepatoma Hep3B and HepG2 cells indicate quantitative
differences between the STAT1 and STAT3 proteins
depending on localization in the cell. It is suggested
that STAT3 can accumulate in the nucleus not only as a
phosphorylated homodimer but also irrespective of its
phosphorylation status. Moreover, the phosphorylated
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STAT3 transcription factor can also form a heterodimer
with phosphorylated STAT1, which in consequence may
lead to enhanced nuclear accumulation of STAT3 as a
result of the action of STAT1-activating factors on the cell
(Pranada et al., 2004; Liu et al., 2005; Reich and Liu, 2006).
Based on the presented changes in NO production
and iNOS expression in the presence of AG490 in PMNs
exposed to NDMA, it can be assumed that the synthesis of
nitric oxide with the involvement of iNOS in these cells is
associated with the JAK/STAT pathway activation.
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Similar results were obtained by Schmidt et al. (2010),
who reported that the JAK/STAT pathway inhibition in
chondrocytes stimulated with a mixture of cytokines (IFN,
IL-1, and TNF) resulted in a decrease in iNOS expression.
Different findings were presented by Ravichandran et al.
(2011), who, after administration of the selective inhibitor
AG490, found neither lower expression of iNOS and STAT
nor reduced NO production in IL-1β–stimulated human
lung cancer cells. They suggested that the lack of changes
in iNOS expression and NO production by these cells may
result from the involvement of another signaling pathway,
e.g., MAP kinases or the NF-κB pathway.
Dai et al. (2009), in a study on IFN-stimulated
splenocytes from mice, demonstrated that the involvement
of the NF-κB pathway synergistic to the JAK/STAT
pathway is essential for the induction of iNOS expression
in these cells.
However, other available data seem to indicate
that the JAK/STAT pathway inhibitor exerts no effect
on the activation of other pathways, including NF-κB
(Nakashima et al., 1999). Our findings showed a reduction
in iNOS expression and NO production by PMNs exposed
to NDMA after AG490 application only at a concentration
of 50 µM, and not at a higher concentration (100 µM). This
can be due to the activation of other signaling pathways
engaged in NO production with the involvement of iNOS
by PMNs treated by NDMA (Ratajczak-Wrona et al., 2011).
Moreover, a study by Nakashima et al. (1999) demonstrated
complete inhibition of NO production by rat mesangial
cells only after application of a mixture containing AG490
at a concentration of 300 µM and herbimycin A (HerA;
1000 ng/mL), the antibiotic inhibiting the activity of
tyrosine kinases.
The differences in results concerning the role of the
JAK/STAT pathway in the induction of iNOS expression
and NO production by cells are probably caused by the
application of another inhibitor. In their experiments on
interferon-treated macrophages, Chen et al. (2002) used
aurintricarboxylic acid (ATA) as a JAK/STAT pathway
inhibitor to check its inhibitory action on the JAK/STAT
pathway, on iNOS expression, and on NO production.
The presence of reactive oxygen species with the
involvement of the JAK/STAT pathway may have an effect

on the changes in iNOS expression and NO production.
This has been confirmed by the findings reported by
Simon et al. (1998), who showed that the activation of
JAK2 kinase in vitro is regulated by reactive oxygen
species. There are data indicating the involvement of
JAK2 kinase in the regulation of oxygen burst in human
granulocytes (Dent et al., 2000).
Our results showed changes in the production of
superoxide anion radical in the presence of AG490
by PMNs exposed to NDMA, which suggests that the
generation of superoxide anion radical by these cells is
associated with JAK/STAT pathway activation.
In conclusion, the presented findings indicate that
NDMA in human neutrophils activates the JAK/STAT
pathway, which plays a role in the production of NO
with the involvement of iNOS and in the generation of
superoxide anion radical by these cells.
The observed changes in transcription factors’
expression in human neutrophils as a result of NDMA
activity may also lead to changes in the course of other
functions controlled by them. These factors may have the
function of an activator or repressor of the transcription
of genes controlling expression of proteins functioning as
factors regulating cell cycle or immunomodulating and
antiapoptotic factors.
Increased production of NO by PMNs can lead to
disturbances in the course of immune responses, e.g.,
inflammatory process, angiogenesis, or apoptosis process.
The data indicate the existence of complex mechanisms
involved in the regulation of NO production with iNOS
and generation of superoxide anion radical by human
PMNs. Further research extended with other functions of
PMNs with the involvement of kinases and transcription
factors will help fully elucidate the molecular mechanism
of NDMA action on these cells and determine potential
threats due to exposure to this compound.
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